Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve after its emergence. Given its importance in viral infection and vaccine development, mutations in the viral Spike gene have been studied extensively; however, the impact of mutations outside the Spike gene are poorly u...
Saved in:
| Main Authors: | Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, Jason Yeung, Birte K. Kalveram, David Walker, Xuping Xie, Pei-Yong Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2023.2209208 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The P132H mutation of SARS-CoV-2 NSP5 relieves its inhibition on interferon-β activation via blocking MAVS degradation
by: Yuxin Zhang, et al.
Published: (2025-07-01) -
Functional and Evolutionary Characterization of the NSP6 Protein in SARS-CoV-2 Omicron Variants
by: Joyhare Barbosa Souza, et al.
Published: (2025-04-01) -
SADS-CoV nsp5 Inhibits Interferon Production by Targeting Kinase IKKε
by: Gaoli She, et al.
Published: (2025-06-01) -
A conserved motif within the NSP2 of SARS-CoV-2 is required for processing of the distal NSP1/NSP2 junction by NSP3
by: Thea Kristensen, et al.
Published: (2025-07-01) -
Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis
by: Rekha Joshi, et al.
Published: (2025-01-01)